The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. (Q53308300)
Jump to navigation
Jump to search
scientific article published on 4 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. |
scientific article published on 4 August 2010 |
Statements
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. (English)
1 reference
Satoru Hagiwara
1 reference
Kazuomi Ueshima
1 reference
Hobyung Chung
1 reference
Mami Yamaguchi
1 reference
Masahiro Takita
1 reference
Seiji Haji
1 reference
Masatomo Kimura
1 reference
Tokuzo Arao
1 reference
Kazuto Nishio
1 reference
Ah-Mee Park
1 reference
Hiroshi Munakata
1 reference
4 August 2010
1 reference
46
1 reference
2
1 reference
212-221
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference